Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Lower Genital Tract Disease|July 1, 2014
Mexican Cervical Cancer Screening Study II: 6-month and 2-year follow-up of HR-HPV women treated with cryotherapy in a low-resource settingDavid Starks, Lucybeth Nieves Arriba, Christine L Enerson, et al.
International Journal of Molecular Sciences|March 28, 2024
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case StudyRaed Sulaiman, Adam Dale, Xiaoqian Lin, et al.
American Journal of Cancer Research|July 15, 2024
<i>Ex vivo</i> platform <i>en route</i> to functional precision medicine: clinical relevance in gynecological cancersRaed Sulaiman, Jennifer C Aske, Luis Rojas Espaillat, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Chemokine analogues show suitable stability for development as microbicidesFabrice Cerini, Alan Landay, Carolyne Gichinga, et al.
Biomedicines|January 21, 2023
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
International Journal of Molecular Sciences|July 14, 2023
Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
American Journal of Cancer Research|March 8, 2024
A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancersRaed Sulaiman, Nischal Koirala, Jennifer C Aske, et al.
Fertility and Sterility|December 15, 2010
Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysisMohamed A Bedaiwy, Ahmed M Abou-Setta, Nina Desai, et al.
Cancers|October 14, 2022
Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
Cancer Medicine|August 30, 2023
A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancersDavid Starks, Luis Rojas-Espaillat, Tobias Meissner, et al.
Pageof 3